PTK2 and plasma cell myeloma: Interestingly, we found that HLSC-EVs directly modulated CSC intracellular pathways (Akt, mTOR and Creb), in analogy with the reported effect of MSC-EVs on the direct modulation of protein FAK phosphorylation in myeloma cells [33].